After eight weeks with a new set of gut microbes, mice can begin to show brain gene-activity patterns that resemble the primate those microbes came from. That is the engineering-like provocation embedded in a new Northwestern University experiment: swap one biological “subsystem” (the gut microbiome) and downstream circuits in another (the developing brain) shift in measurable, pathway-level ways. The work matters because humans carry the largest brain relative to body size among primates, and the central puzzle has never been brain tissue alone it is the long-term metabolic budget required to build and run it.
In the study, researchers colonized germ-free mice with gut microbes from two large-brained primates (humans and squirrel monkeys) and one smaller-brained primate (macaques), then examined neurodevelopmental signatures. The team reported that mice hosting microbes from the larger-brained primates showed higher activity in genes tied to energy production and synaptic plasticity, a set of processes that supports learning by changing synaptic strength and structure. By contrast, mice given macaque-associated microbes showed lower activity in those same pathways. The experiment’s deeper jolt came from cross-checking: “What was super interesting is we were able to compare data we had from the brains of the host mice with data from actual macaque and human brains, and to our surprise, many of the patterns we saw in brain gene expression of the mice were the same patterns seen in the actual primates themselves,” said Katie Amato. “In other words, we were able to make the brains of mice look like the brains of the actual primates the microbes came from.”
The result reframes microbes as more than passive passengers or simple calorie extractors. They behave like a distributed metabolic layer that can push developmental programs toward distinct operating points more ATP-generating capacity here, more plasticity-related transcription there without editing the host genome. That aligns with broader microbiome evidence that microbial metabolites can move beyond the gut. For example, short-chain fatty acids produced by microbial fermentation can enter circulation and are described as capable of crossing the blood–brain barrier via transporters, creating plausible biochemical routes from diet and microbes to neural tissue energetics.
One finding demands especially careful reading: mice colonized with microbes from the smaller-brained primate showed a gene-expression pattern associated with ADHD, schizophrenia, bipolar disorder, and autism. The study does not diagnose mice with human conditions, but it does place additional weight on early-life timing when microbial communities assemble and neurodevelopment is most plastic and on the possibility that microbial composition contributes to risk-relevant biology rather than merely correlating with it.
The work also implicitly raises a design constraint for future therapies: microbial interventions are not interchangeable and “healthy” may be species, context, and developmental-stage specific.
Clinical translation, however, runs into the hard realities of microbiome manipulation. Even an established procedure such as faecal microbiota transplantation (FMT) remains variably standardized, with ongoing regulatory and safety concerns that stem from transferring complex, partly uncharacterized living communities. For neuroscience-adjacent ambitions tuning development, resilience, or psychiatric risk the bar for defining what is being transferred, when, and to whom becomes even higher.
For engineers of biological systems, the message is not that the gut “controls” the brain. It is that the brain develops inside an energy-and-signal landscape partly built by microbes, and that landscape appears adjustable in ways evolution may have repeatedly exploited.
